Paclitaxel & Myelosuppression

3.3%

of users reported Myelosuppression

66.8%

also reported Severe reaction

72.0%

are women

Severe reaction

66.8%

Hospitalization

28.0%

Life-threatening condition

3.9%

Disability

0.9%

Death

0.4%

Paclitaxel: general information

20 - 29 years

1.2%

30 - 39 years

6.8%

40 - 49 years

15.0%

50 - 59 years

22.6%

60 - 69 years

31.5%

70 - 79 years

20.3%

80 - 89 years

2.6%